Prevalence of prediabetes 18.0 and 24.0 percent among adolescents and young adults, respectively

Decline seen across income levels, including SNAP participants

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.U.S. Life …

We have all read about the use of AI (artificial intelligence) by companies such as Google, Amazon and Facebook, to know what we want to order before we even look for it. You can see that when you place an order and they offer to have the product to you …

Conflicting findings on metformin’s possible relationship to cancer. 

Adding Dulaglutide, Liraglutide or Semaglutide (GLP-1 agonists) to existing treatment for type 2 diabetes has major cardiovascular benefits.  Exenatide* and Lixisenatide were neutral for providing cardiovascular benefits.

Early life programming may contribute to the development of obesity.

I was talking about insulin use with my interns today. We were talking about the Team NovoNordisk cycling club, and they figured that these guys would never need insulin because they exercised so much. They were surprised that the riders’ glucose could climb so much with all that activity. As …

A man with type 1 diabetes started an exercise program to help him manage his early morning highs. He exercised every evening, at which time his glucose levels would drop during and after exercise. Thinking that exercise would lower his early morning highs, he did not take his insulin before exercise. He was surprised to see his glucose would go up after exercise rather than go down.

Can a diagnosis of resistant hypertension give clinicians a clue on what patients can expect for their future?